We honor 100 of the leading innovators in pathology and laboratory medicine by celebrating their success at the cutting edge of the field.
In-depth analysis of next-generation sequencing can help personalize cancer treatment and drive the adoption of precision medicine
A new kind of deep learning model uses nonlinear information to draw new associations between genes and diseases
Pharmacogenomic testing can only improve patient care if it’s clinically validated, judiciously applied, and easily understood by healthcare providers
New research shows that genome-wide testing of DNA methylation can diagnose previously unsolved cases of neurodevelopmental and congenital anomalies
The transcriptome of circulating neutrophils may contain a signature that allows the early detection of intracranial aneurysms via blood test
A new study uses machine learning to perform meta-analysis of eight metagenomic studies linking gut microbial signatures with colorectal cancer.
Combining metabolomics and DNA sequencing could be the key to discovering new inborn errors of metabolism in children.
Tieneke B. M. Schaaij-Visser,
Gerhard A. Zielhuis
Study participants can offer a valuable resource to researchers deciding which unsolicited findings to report and why.
Decentralized genomic testing in China will allow earlier breast cancer diagnosis and more personalized treatment decisions
A microfluidic device reveals new insights into the function of circulating tumor cells, providing vital information on how cancers metastasize.
Send me the latest from The Pathologist.
by Thermo Fisher Scientific
Whilst NGS has been instrumental to precision oncology research progress, practical hurdles have still been hindering its broad implementation…………Not anymore.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.